What Myeloma Patient Monitoring Occurs After Induction Therapy?
https://vimeo.com/930138670 What is involved in myeloma patient monitoring following induction therapy? Expert Dr. Ola Landgren from University of Miami Sylvester Comprehensive Cancer Center discusses some common treatment and monitoring scenarios that he…
Targeting of Myeloma Disease Progression and Bispecific Antibody Advantages
https://vimeo.com/930138395 How can myeloma progression and bispecific antibodies be used for myeloma care? Expert Dr. Ola Landgren from University of Miami Sylvester Comprehensive Cancer Center discusses how disease progression and genomic features…
What Are the Latest Artificial Intelligence Advancements for Myeloma?
https://vimeo.com/930138514 What artificial intelligence advancements have emerged for myeloma? Expert Dr. Ola Landgren from University of Miami Sylvester Comprehensive Cancer Center discusses the IRMMa prediction model for myeloma care, factors that go…
What Are the Benefits of Myeloma Consults and Second Opinions?
https://vimeo.com/930138742 What can myeloma consults and second opinions bring to patients? Expert Dr. Ola Landgren from University of Miami Sylvester Comprehensive Cancer Center discusses the benefits of consults, second opinions, and myeloma…
Self-Advocacy in Myeloma Care | Advice From an Expert
https://vimeo.com/930272098 What questions should myeloma patients ask their doctor about a treatment plan? Myeloma expert Dr. Omar Nadeem shares key advice and emphasizes the importance of patients engaging with their…
Personalized Medicine for Myeloma Treatment | What Patients Should Know
https://vimeo.com/930272181 What is personalized medicine, and how can myeloma patients access this type of care? Myeloma expert Dr. Omar Nadeem defines personalized medicine and shares how test results can impact…
Next Generation Myeloma Treatment Options
https://vimeo.com/930272264 What new myeloma therapies are showing promise? Myeloma expert Dr. Omar Nadeem shares an update on emerging myeloma treatment research, including CELMoDs, and shares advice for a having a…
Evolving Myeloma Treatment Options | Bispecific Antibody Therapy
https://vimeo.com/930271946 What are bispecific antibodies, and how are they advancing myeloma care? Dr. Omar Nadeem of Dana-Farber Cancer Institute discusses the role of this new therapy in myeloma care, shares…
Evolving Myeloma Treatment Options | CAR T-Cell Therapy
https://vimeo.com/930271830 What is CAR T-cell therapy, and who is it right for? Dr. Omar Nadeem of Dana-Farber Cancer Institute discusses the role of this therapy in myeloma care and shares…
Clinical Trials for Myeloma Treatment | Essential Information for Patients
https://vimeo.com/930271725 How do clinical trials advance treatment options for myeloma? Dr. Omar Nadeem discusses the important role of clinical trials in improving patient care, key questions to ask your care…
Myeloma Patient Expert Q&A: Dr. Ola Landgren
https://vimeo.com/929981922 START HERE bridges the gap between expert and patient voices, empowering myeloma patients to feel comfortable asking precise questions of their healthcare team. In this webinar, Dr. Ola Landgren…
Evolving Myeloma Treatment Options: How You Can Access Cutting-Edge Care
https://vimeo.com/928072269 With the quickly evolving landscape of myeloma treatment and care, it’s important to work with your healthcare team to determine a care plan. In this program, Dr. Omar Nadeem…